From: Pelvic radiotherapy for cervical cancer affects importantly the reproducibility of cytological alterations evaluation
Cytological Abnormalities
Time < 364 days
Time ≥ 364 days
P-value*
ASC-US and LSIL
3 (60.0%)
2 (40.0%)
1.00
AGC, HSIL and ASC-H
9 (47.4%)
10 (52.6%)